Lista de obras - David P Sonne - Dominio Público Uruguay

Bile acid sequestrants for glycemic control in patients with type 2 diabetes: A systematic review with meta-analysis of randomized controlled trials

artículo científico publicado en 2017

Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretion

artículo científico

Bile acid sequestrants: glucose-lowering mechanisms and efficacy in type 2 diabetes.

artículo científico publicado en 2014

Biomarkers and immunoassay kits: a matter of growing concern

artículo científico publicado en 2015

Cardiovascular effects of alpha-linolenic acid--a possible role of glucagon-like peptide-1.

artículo científico publicado en 2013

Cholecystokinin-Induced Gallbladder Emptying and Metformin Elicit Additive Glucagon-Like Peptide-1 Responses

artículo científico publicado en 2016

Clinical relevance of the bile acid receptor TGR5 in metabolism.

artículo científico publicado en 2016

Comment on American Diabetes Association. Standards of Medical Care in Diabetes-2017. Diabetes Care 2017;40(Suppl. 1):S1-S135

artículo científico publicado en 2017

Comment on Xu et al. Effects of Metformin on Metabolite Profiles and LDL Cholesterol in Patients With Type 2 Diabetes. Diabetes Care 2015;38:1858-1867

scientific article published on 01 December 2015

Determinants of Fasting Hyperglucagonemia in Patients with Type 2 Diabetes and Nondiabetic Control Subjects

artículo científico publicado en 2018

Diabetes and its lack of causal biomarkers

artículo científico publicado en 2016

Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.

artículo científico publicado en 2017

Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion

artículo científico publicado en 2016

Effects of liraglutide on gallbladder emptying: A randomized, placebo-controlled trial in adults with overweight or obesity.

artículo científico publicado en 2018

Evidence connecting old, new and neglected glucose-lowering drugs to bile acid-induced GLP-1 secretion: A review.

artículo científico publicado en 2017

Glucose-lowering effects and mechanisms of the bile acid-sequestering resin sevelamer

artículo científico publicado en 2018

Hyponatraemia as the cause of severe cerebral symptoms

artículo científico publicado en 2013

Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.

artículo científico publicado en 2016

Involvement of glucagon-like peptide-1 in the glucose-lowering effect of metformin.

artículo científico publicado en 2016

Mechanism-Based Modeling of Gastric Emptying Rate and Gallbladder Emptying in Response to Caloric Intake

artículo científico publicado en 2016

Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes

artículo científico publicado en 2018

Model-Based Prediction of Plasma Concentration and Enterohepatic Circulation of Total Bile Acids in Humans

artículo científico publicado en 2018

On the role of gallbladder emptying and incretin hormones for nutrient-mediated TSH suppression in patients with type 2 diabetes

artículo científico publicado en 2014

Pancreatic Amylase and Lipase Plasma Concentrations Are Unaffected by Increments in Endogenous GLP-1 Levels Following Liquid Meal Tests

artículo científico publicado en 2015

Postprandial Plasma Concentrations of Individual Bile Acids and FGF-19 in Patients With Type 2 Diabetes

artículo científico publicado en 2016

Postprandial Plasma Concentrations of ProANP in Patients with Type 2 Diabetes and Healthy Controls

artículo científico publicado en 2017

Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1.

artículo científico publicado en 2014

Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients

artículo científico publicado en 2012

Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart

scientific article published on 13 October 2007

Remission of Bile Acid Malabsorption Symptoms Following Treatment With the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide

scientific article published on 06 April 2019

Restoration of enteroendocrine and pancreatic function after internal hernia and short bowel syndrome in a young woman with gastric bypass - a 2-year follow-up.

artículo científico publicado en 2018

Sevelamer in a diabetologist's perspective: a phosphate-binding resin with glucose-lowering potential.

artículo científico publicado en 2014

Sulfonylurea versus metformin monotherapy in patients with type 2 diabetes: a Cochrane systematic review and meta-analysis of randomized clinical trials and trial sequential analysis

artículo científico publicado en 2014

Sulphonylurea monotherapy for patients with type 2 diabetes mellitus

artículo científico publicado en 2015

Sulphonylurea monotherapy for patients with type 2 diabetes mellitus

artículo científico publicado en 2013

[Effects of glucagon-like peptides on gallbladder motility] ⬇️

artículo científico publicado en 2018

Lista de obras de David P Sonne

Bile acid sequestrants for glycemic control in patients with type 2 diabetes: A systematic review with meta-analysis of randomized controlled trials

Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretion

Bile acid sequestrants: glucose-lowering mechanisms and efficacy in type 2 diabetes.

Biomarkers and immunoassay kits: a matter of growing concern

Cardiovascular effects of alpha-linolenic acid--a possible role of glucagon-like peptide-1.

Cholecystokinin-Induced Gallbladder Emptying and Metformin Elicit Additive Glucagon-Like Peptide-1 Responses

Clinical relevance of the bile acid receptor TGR5 in metabolism.

Comment on American Diabetes Association. Standards of Medical Care in Diabetes-2017. Diabetes Care 2017;40(Suppl. 1):S1-S135

Comment on Xu et al. Effects of Metformin on Metabolite Profiles and LDL Cholesterol in Patients With Type 2 Diabetes. Diabetes Care 2015;38:1858-1867

Determinants of Fasting Hyperglucagonemia in Patients with Type 2 Diabetes and Nondiabetic Control Subjects

Diabetes and its lack of causal biomarkers

Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.

Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion

Effects of liraglutide on gallbladder emptying: A randomized, placebo-controlled trial in adults with overweight or obesity.

Evidence connecting old, new and neglected glucose-lowering drugs to bile acid-induced GLP-1 secretion: A review.

Glucose-lowering effects and mechanisms of the bile acid-sequestering resin sevelamer

Hyponatraemia as the cause of severe cerebral symptoms

Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.

Involvement of glucagon-like peptide-1 in the glucose-lowering effect of metformin.

Mechanism-Based Modeling of Gastric Emptying Rate and Gallbladder Emptying in Response to Caloric Intake

Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes

Model-Based Prediction of Plasma Concentration and Enterohepatic Circulation of Total Bile Acids in Humans

On the role of gallbladder emptying and incretin hormones for nutrient-mediated TSH suppression in patients with type 2 diabetes

Pancreatic Amylase and Lipase Plasma Concentrations Are Unaffected by Increments in Endogenous GLP-1 Levels Following Liquid Meal Tests

Postprandial Plasma Concentrations of Individual Bile Acids and FGF-19 in Patients With Type 2 Diabetes

Postprandial Plasma Concentrations of ProANP in Patients with Type 2 Diabetes and Healthy Controls

Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1.

Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients

Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart

Remission of Bile Acid Malabsorption Symptoms Following Treatment With the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide

Restoration of enteroendocrine and pancreatic function after internal hernia and short bowel syndrome in a young woman with gastric bypass - a 2-year follow-up.

Sevelamer in a diabetologist's perspective: a phosphate-binding resin with glucose-lowering potential.

Sulfonylurea versus metformin monotherapy in patients with type 2 diabetes: a Cochrane systematic review and meta-analysis of randomized clinical trials and trial sequential analysis

Sulphonylurea monotherapy for patients with type 2 diabetes mellitus

Sulphonylurea monotherapy for patients with type 2 diabetes mellitus

[Effects of glucagon-like peptides on gallbladder motility] ⬇️